PDA

View Full Version : Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-l

RSSBot
29th March 2009, 04:09 AM
*Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a...

More... (http://www.wound-forum.org/forum/showthread.php?t=1128&goto=newpost)